| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22bcb0efb17af5d7eb47a6365dad2333 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3334 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-16827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1408 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-14 |
| filingDate |
2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3e44ed801e4b190a5b85ef6f62e6f2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_690b102a8d2fd00939cab0a2ce9ef282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_750efe6f3b94b8bff360a9f42948ac3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08b1dcdbbaad21d6d33a566f29e01b48 |
| publicationDate |
2023-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2023017117-A1 |
| titleOfInvention |
Infusion system with concurrent tpn/insulin infusion |
| abstract |
An infusion system to provide concurrent TPN/insulin infusion including: a fluid administration set having a primary line in fluid communication with the TPN source, a secondary line in fluid communication with the insulin source, and a common outlet line; a pump operable to removably receive the fluid administration set, the pump being operable to concurrently move the TPN solution through the primary line in response to a TPN solution flow rate signal and the insulin solution through the secondary line in response to an insulin solution flow rate signal; and a flow controller operable to provide the TPN solution flow rate signal and the insulin solution flow rate signal to the pump. The flow controller is further operable to vary the TPN solution flow rate signal and the insulin solution flow rate signal to vary a ratio of TPN solution to insulin solution provided to the common outlet line. |
| priorityDate |
2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |